← Oncology Approval Tracker

FDA DECISION ·

Methylnaltrexone bromide injection (first generic)

methylnaltrexone bromide · Actavis

First generic approvalFirst genericOpioid-induced constipation in cancer and palliative care
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

The first generic of the referenced prefilled injections for opioid-induced constipation, including in adults with advanced illness or active cancer pain requiring increased opioid dosing for palliative care. The product also has a non-cancer indication.

LAMPGEN ANALYSIS

Why it matters

The decision adds a supportive-care option in a cancer pain setting as well as non-cancer use.

What research teams should watch

Record the opioid regimen and screen for known or suspected bowel obstruction before dispensing the appropriate syringe.

PRIMARY RECORDS

Sources